MITF-siRNA formulation is a safe and effective therapy for human melasma - Wikidata - wikimedia - TriplyDB

MITF-siRNA formulation is a safe and effective therapy for human melasma

MITF-siRNA formulation is a safe and effective therapy for human melasma

http://www.wikidata.org/entity/Q34556920

about

Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.Progress toward in vivo use of siRNAs-II MicroRNA-218 inhibits melanogenesis by directly suppressing microphthalmia-associated transcription factor expression.Knock-down of ABCE1 gene induces G1/S arrest in human oral cancer cells.Depleting ABCE1 expression induces apoptosis and inhibits the ability of proliferation and migration of human esophageal carcinoma cells.Topical delivery of siRNA into skin using SPACE-peptide carriers.siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown.Visualization of plasmid delivery to keratinocytes in mouse and human epidermis.Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation.Effect of silencing SATB1 on proliferation, invasion and apoptosis of A549 human lung adenocarcinoma cells Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers miRNAs in inflammatory skin diseases and their clinical implications.microRNAs in Psoriasis.Therapeutic RNAi robed with ionic liquid moieties as a simple, scalable prodrug platform for treating skin disease.Advances in the Application and Impact of MicroRNAs as Therapies for Skin Disease The changes of microRNA expression profiles and tyrosinase related proteins in MITF knocked down melanocytes.

P2860

Q26752186-5A25A74C-39BE-423C-88D9-176DA7BD9CFA Q28085200-A23BBEEA-74D1-4851-AEF4-926E070F59A1 Q28255877-BF4E8463-197A-4D76-9468-2AD3D8411CE4 Q34143012-39943466-5DCA-40B5-A713-345CF98CFBD1 Q34371150-A8295660-8946-43A1-90B2-9CB5A12A03EA Q35097836-69389F25-0B61-4E7E-A553-173EF70FA9DB Q35587915-0F7AEB8B-4156-4495-A353-786D338085F8 Q35590281-31480AE5-76BF-4E51-84E2-A83A9CA638BB Q35619666-323C3733-35AC-45C4-A672-5123E1570C82 Q36132897-7F5EE6E2-1930-4CA3-A7C6-AE109654A8F3 Q36206228-BB805E9C-7900-46B5-A2A7-7C82BC5C3E6E Q36762760-9FEED2F2-5584-4B78-91CF-8366F1661277 Q38365504-96E3D454-889A-4C83-B51F-2D693F810C28 Q38708656-5C1A0741-D011-478D-8334-EDFEAC6E93B3 Q39406180-33BA33E5-A911-41EE-8DCD-838345D24C8B Q42362861-60E6041E-8D71-4B3F-A9E8-84997270F444 Q54296428-1C29C4FD-4095-4DE2-BEDF-63D211B26AB2

P2860

MITF-siRNA formulation is a safe and effective therapy for human melasma

http://www.wikidata.org/entity/Q34556920

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

MITF-siRNA formulation is a safe and effective therapy for human melasma

@ast

MITF-siRNA formulation is a safe and effective therapy for human melasma

@en

MITF-siRNA formulation is a safe and effective therapy for human melasma

@nl

type

label

MITF-siRNA formulation is a safe and effective therapy for human melasma

@ast

MITF-siRNA formulation is a safe and effective therapy for human melasma

@en

MITF-siRNA formulation is a safe and effective therapy for human melasma

@nl

prefLabel

MITF-siRNA formulation is a safe and effective therapy for human melasma

@ast

MITF-siRNA formulation is a safe and effective therapy for human melasma

@en

MITF-siRNA formulation is a safe and effective therapy for human melasma

@nl

P1433

Q34556920-5DB4B3FE-2E71-422B-9E43-8D9937ED283D

P1476

Q34556920-8FF37B53-6165-417D-803B-EFE798FBE6C0

P2093

Q34556920-0B6FE118-F7AF-4623-9960-4AD7CFEE932D

Q34556920-11487457-56B9-4A93-BCA7-3AA14AD2BDF3

Q34556920-26CC8E86-7826-4004-A06B-E0219738AEB6

Q34556920-4402364C-DB60-46BE-8489-B6D4A05E88A5

Q34556920-6D997425-7A46-4B33-8CBA-15764ED2A0EE

Q34556920-789B936C-E585-445C-BC79-F8611B39D107

Q34556920-7DCDD25E-0ED2-47FE-A301-454116C9DD0D

Q34556920-954EAF1B-1258-401F-AB0D-E1EA34FDAD01

Q34556920-9797F399-FB52-48C3-9C50-4BF30A8BDD9A

Q34556920-AA637560-2584-4E37-B6F6-77D7B1AD4759

P2860

Q34556920-001B1C6E-374D-4897-BD11-5E52B7A495EA

Q34556920-067B2C19-68EA-49B6-BD5A-8E5338C98E06

Q34556920-16DBF7B3-4DC6-49DD-BF2E-D3358FE7534B

Q34556920-175BCD9A-198B-4BC7-B3D0-25ADC6795027

Q34556920-18C0A8E1-9520-44E1-A969-21F67BB97A33

Q34556920-1A8BDF37-E5E7-4952-B3AB-5EB1CB48F6BF

Q34556920-21401839-DFCC-4F82-81C0-2978E6751CEF

Q34556920-22E2131D-B2BB-4F76-BBA1-9D4D9B2F42D8

Q34556920-332F9E4A-4E9C-4472-960D-56609FB0CC16

Q34556920-365AA757-2717-47FF-B58B-DE5B9F050616

P304

Q34556920-D7DFFA39-E3EA-47D2-9DF2-E1D6216BFCD1

P31

Q34556920-1E51161F-07A2-432D-824C-FB25043C2D37

P356

Q34556920-88CFEE69-EB98-40C6-BCC6-647F7D2D1D1F

P433

Q34556920-8BD88719-7FD4-4199-AA84-0739FF695C37

P478

Q34556920-F70910D2-2631-459B-A174-37DB8D1253C4

P577

Q34556920-B3F97322-8E23-475C-A4F8-FD4915055A6C

P5875

Q34556920-4B5B3C77-81A3-43C4-BEEC-895B4819B8B4

P698

Q34556920-8E38FF23-14B1-425B-8F7F-49C7DEC3D301

P932

Q34556920-792B5743-DA69-4FD4-8A30-FD23CDC0406C

P356

P1433

Molecular Therapy

P1476

MITF-siRNA formulation is a safe and effective therapy for human melasma

@en

P2093

Chui Liu

http://www.w3.org/2001/XMLSchema#string

Di Guan

http://www.w3.org/2001/XMLSchema#string

Fangyuan Que

http://www.w3.org/2001/XMLSchema#string

Guang Zhao

http://www.w3.org/2001/XMLSchema#string

Henming Jia

http://www.w3.org/2001/XMLSchema#string

Hongjie Zhang

http://www.w3.org/2001/XMLSchema#string

James Q Yin

http://www.w3.org/2001/XMLSchema#string

Kejun Dou

http://www.w3.org/2001/XMLSchema#string

Qingqi Yang

http://www.w3.org/2001/XMLSchema#string

Rusong Meng

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability

MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma

Identification of Aim-1 as the underwhite mouse mutant and its transcriptional regulation by MITF

Skin lightening preparations and the hydroquinone controversy

Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas

Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation.

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.

Clinical practice. Treatment of photoaging.

Transdermal protein delivery by a coadministered peptide identified via phage display.

Noninvasive techniques for the evaluation of skin color.

P304

362-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2010.263

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49647028

http://www.w3.org/2001/XMLSchema#string

P698

21119619

http://www.w3.org/2001/XMLSchema#string

P932

3034856

http://www.w3.org/2001/XMLSchema#string